ReviewFrontiers in cardiovascular medicine2023
New therapeutic approach for tricuspid regurgitation: Transcatheter tricuspid valve replacement or repair.
Review in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Transcatheter tricuspid valve treatment: a growing armamentarium of devices.European heart journal supplements : journal of the European Society of Cardiology · 2026Article
- Management of Tricuspid Valve Regurgitation Consensus Recommendations.Heart views : the official journal of the Gulf Heart Association · 2026Review
- Transcatheter Tricuspid Valve Interventions to Manage Tricuspid Regurgitation: A Narrative Review.Reviews in cardiovascular medicine · 2025Review
- Association of Diuretic Dosage With Outcomes in Patients With Hemodynamically Significant Isolated Tricuspid Valve Regurgitation.Journal of the American Heart Association · 2025Article
- Exploring Imaging Depth: A Pilot Study About 2D vs. 4D Echocardiography for Tricuspid Valve Evaluation.Reviews in cardiovascular medicine · 2025Article
- Transcatheter Tricuspid Valve Replacement: Current Options and Future Perspectives.Reviews in cardiovascular medicine · 2025Review
- Atrial Functional Tricuspid Regurgitation: A Comprehensive Review of Pathophysiology, Diagnosis, and Management Strategies.Reviews in cardiovascular medicine · 2024Review
- Cardiac Surgery and Transcatheter Intervention for Valvular Heart Disease in Carcinoid Syndrome: Risk Factors, Outcomes, and Evolving Therapeutic Strategies.Journal of cardiovascular development and disease · 2024Review
- Efficacy and Safety of Cardioband in Patients with Tricuspid Regurgitation: Systematic Review and Meta-Analysis of Single-Arm Trials and Observational Studies.Journal of clinical medicine · 2024Review
- Key Imaging Factors for Transcatheter Management of Tricuspid Regurgitation: Device and Patient Selection.Journal of clinical medicine · 2024Review
- Tricuspid Regurgitation Complicating Heart Failure: A Novel Clinical Entity.Reviews in cardiovascular medicine · 2024Review
- New Therapeutic Advances in the Management of Tricuspid Valve Regurgitation.Journal of clinical medicine · 2024Review
- Transcatheter Therapy for the Tricuspid Valve: A Focused Review of Edge-to-Edge Repair and Orthotopic Valve Replacement.Current cardiology reports · 2024Review
- Tricuspid regurgitation and heart failure: the fate of treated vs. untreated cohort in the percutaneous era.European heart journal. Imaging methods and practice · 2024Article
- Percutaneous repair of tricuspid regurgitation.European heart journal supplements : journal of the European Society of Cardiology · 2024Article
- Transcatheter Management of Tricuspid Regurgitation: A Review of Contemporary Evidence.Heart international · 2024Review
- Cardiac CT Beyond Coronaries: Focus on Structural Heart Disease.Current heart failure reports · 2023Review
- A multifunctional soft robot for cardiac interventions.Science advances · 2023Article
- Multimodality imaging for transcatheter tricuspid valve repair and replacement.Frontiers in cardiovascular medicine · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The tricuspid valve is a complex structure with normal function dependent on the leaflet morphology, right atrial and annular dynamics, and right ventricular and chordal support. Thus, the pathophysiology of tricuspid regurgitation (TR) is equally complex and current medical and surgical management options are limited. Transcatheter devices are currently being investigated as possible treatment options with lower morbidity and mortality than open surgical procedures. These devices can be divided by their implant location/mechanism of action: leaflet approximation devices, annuloplasty devices, orthotopic valve implants, and heterotopic valve implants. The current review will discuss each class of transcatheter device therapy, and further delve into the current understanding of who and when to treat. Finally, we will include a brief discussion of the future of device and surgical therapy trials for TR and the remaining questions to answer about this complex disease process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.